1. Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees Publication: Washington, DC : United States Government Accountability Office, March 2023 Subject(s): Drugs, Generic -- economicsDrug Development -- legislation & jurisprudenceGovernment RegulationLegislation, MedicalPatents as Topic -- legislation & jurisprudencePrescription Fees -- legislation & jurisprudenceUnited States
2. Assessing user fees under the Generic Drug User Fee Amendments of 2017 Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Industry -- legislation & jurisprudenceDrugs, Generic -- economicsUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
